FDA Inspection 1268372 — Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
The FDA completed an inspection of Guilin China Resources Tianhe Pharmaceutical Co., Ltd. on Mar 28, 2025 in Guilin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Guilin (China)